In this section you will be able to find important information, including:

  • How we use your personal information and your right to access that information;
  • Information relating to cookies and online tracking technologies; and
  • Warnings in respect of fraud, misrepresentation, fraudulent or fake websites and phishing.

Role of AVAT

AVAT NFCS Trust (“AVAT”), with its offices at 7th Floor, Happy World House, 37 Sir William Newton Street, Port-Louis 11328, Mauritius, is responsible for certain obligations in connection with the AVAT No Fault Compensation Scheme (the “Program”) (for example the payment of claims under the Program). AVAT also instructs ESIS, Inc. (“ESIS”), a claims administration company, to administer the Program.

AVAT does not collect or hold your personal data as part of the Program, although it instructs ESIS to do so. Please refer to the Privacy Policy and Cookie Policy which explain how and why ESIS uses personal data in connection with the Program and explain your rights in respect of the personal data processed by ESIS. To the extent that ESIS shares any personal data with AVAT in connection with the Program, AVAT’s use of this personal data and your rights in respect of that personal data will be the same as described in Privacy Policy and Cookies Policy, and you should contact ESIS regarding any questions or requests you have (and ESIS will be able to resolve them) in the same way as set out in those policies.

Role of ESIS

ESIS administers the Program. Under the Program, ESIS needs to collect certain personal data about the patient, their authorized representative (if applicable), and any healthcare professional providing supporting evidence. The personal data ESIS collects is set out in the Application Form and Supporting Evidence Form, and may also be supplemented by additional information collected from healthcare professionals who have treated the Patient, as well as third party sanctions and anti-fraud databases.

ESIS uses the personal data it collects in order to consider whether a claim is eligible for payment under the Program, to communicate with the Patient or their representative, and to process any payment made on a claim (if eligible). Where necessary, the Patient’s personal data may be shared with third parties including ESIS’s service providers, reinsurers, and government health and law enforcement agencies.

You may have certain rights in respect of the personal data processed by ESIS. More information about these, as well as other conditions that apply to ESIS’ use of your personal data, can be found in ESIS’s full Privacy Policy and Cookies Policy.

AVAT NFCS Trust

The AVAT No Fault Compensation Scheme Trust of 7th Floor, Happy World House, 37 Sir William Newton Street, Port-Louis 11328, Mauritius, incorporated on behalf of the AU Member States and CARICOM Member States for the purposes of establishing and maintaining in place the AVAT No Fault Compensation Scheme.

AVAT

The African Vaccine Acquisition Trust of 7th Floor, Happy World House, 37 Sir William Newton Street, Port-Louis 11328, Mauritius, a centralised negotiating, purchasing, and payment agent incorporated on behalf of the AU Member States and CARICOM Member States for the purchase of COVID-19 vaccines pursuant to the AVAT Framework.

AVAT No Fault Compensation Scheme

A pan-African and pan-Caribbean no fault compensation program established by the AVAT NFCS Trust and administered by the Administrator with the aim of providing compensation to Patients who suffer an Injury (the most likely cause of such Injury (based on the balance of probabilities) being the result of a Vaccine or its administration, without the need for the Patient to demonstrate a defect in the relevant Vaccine or any fault by any person.

Program

The AVAT No Fault Compensation Scheme, as detailed in the Protocol and its Schedules.

Application

A written claim for compensation completed by an Applicant on the application form approved by and provided by the Administrator, as set forth in Schedule 2 to the Program's Protocol, which must be accompanied by all Supporting Evidence, using the prescribed form in Schedule 3 to the Program’s Protocol.

Supporting Evidence

The supporting evidence, using the form in Schedule 3 to the Program's Protocol, required to evaluate an Application and that shall include:

  1. detailed medical documentation from a Registered Health Professional describing the Injury and medical treatment required as a result of the Injury, together with details of any Hospitalization or prolonged Hospitalization, including but not limited to admission and discharge records;
  2. a description of the nature, extent, functional impact and prognosis of the Injury, as assessed by the Registered Health Professional.
  3. a statement from the Registered Health Professional that the Injury was, in the Registered Health Professional’s opinion, the result of the Vaccine or its administration;
  4. certification from a Registered Health Professional of when, where and which Vaccine was administered;
  5. in the case of death, a death certificate and any other documentation available from a Registered Health Professional of the cause and manner of death; and
  6. any further evidence that the Administrator may deem necessary to adjudicate the Application, and/or Receivable Claim, as applicable, guided, as appropriate, by the Scientific Advisory Committee, the Review Panel, and/or the Appeals Panel.
Patient

A resident, a citizen or person within the population of a Participating Member State who claims or in respect of whom it is claimed that he or she has suffered or sustained a Serious Adverse Event which is associated with a Vaccine or its administration, and which, in turn, has resulted in an Injury.